|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $2,687 and $2,690, respectively | ||||||||||||||||||||
| Prepaids and other assets | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Noncurrent assets of discontinued operations | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Customer deposits | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Litigation contingency | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||||
| Long-term payable | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Common Stock, $0.00001 par value 900,000,000 shares authorized; 213,853,720 issued and 167,117,937 outstanding at June 30, 2026 and 207,785,762 issued and 161,049,979 outstanding at December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost: 46,735,783 shares held at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Accumulated earnings (deficit) | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| TOTAL EQUITY | ||||||||||||||||||||
| Equity attributable to noncontrolling interest | ||||||||||||||||||||
| TOTAL LIABILITIES AND EQUITY | ||||||||||||||||||||
Loading...